Document is current
Any future updates will be listed below
-
Authors
Hark, Lisa A.
Gorroochurn, Prakash
Tang, Haotian
Torres, Desiree R.
Blackburn, Brendan
Maruri, Stefania C.
Diamond, Daniel F.
Harizman, Noga
Wang, Qing
Wang, Yujia
Liebmann, Jeffrey M.
Cioffi, George A.
Horowitz, Jason D.
Park, Lisa
-
Funding
Funding for this research was provided by:
National Center for Chronic Disease Prevention and Health Promotion (U01DP006435, U01DP006436)
Research to Prevent Blindness
- License Information
-
More Information
Article History
Received: 13 August 2024
Revised: 13 November 2024
Accepted: 21 December 2024
First Online: 15 January 2025
Declarations
:
: The study was approved by the Columbia University Institutional Review Board and was conducted in accordance with the Declaration of Helsinki (CUIMC IRB #AAAR9162). The study is registered with ClinicalTrials.gov (NCT04271709).
: All participants provided informed consent before participating in this study.
: The authors have made the following disclosures: JDH: Member Medical Policy Council of Superior Vision. JML has received research support from National Institutes of Health, Heidelberg Engineering, Novartis, Inc. and is a consultant to Allergan, Inc., Genentech, Inc., Thea Pharmaceuticals, Inc., and Janssen Pharma, Inc. All other authors have no relevant financial or non-financial interests to disclose.
